Feed QDEL
QD

QuidelOrtho

QDEL · NASDAQ

$10.86 +1.02% (+$0.11)
1M -25.05%
Market Cap $740.6M
P/E Ratio -
Div. Yield -
ROE 55.30%

Bulios Fair Price

$7.71

29.0% downside

Trenutna cena

$10.86

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica QDEL trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Odkleni pošteno ceno

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.28x
P/B 0.42x
P/E N/A
Growth
0 /100
Declining
Rev. growth 5.80%
Book val. growth 26.99%
EPS growth N/A
Profitability
18 /100
Weak
Gross margin 44.60%
FCF margin 7.90%
Net margin 39.20%
Quality
6 /100
Poor
ROIC 16.34%
Asset turnover 0.47x
ROE 55.30%
Debt
27 /100
High
Debt/Equity 1.73x
Int. coverage -4.29x
Current ratio 1.39x
Stability
56 /100
Moderate
Beta 0.68x
Profitable years 0
Rev. volatility 3.39%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o QDEL
Online

O podjetju

QuidelOrtho Corporation is a global biotechnology company specializing in diagnostics and rapid testing. Formed through the merger of Quidel Corporation and Ortho Clinical Diagnostics, it has become a leader in diagnostic tests, focusing on infectious disease detection, immunoassays, and tests for chronic conditions. QuidelOrtho develops innovative diagnostic tools that accelerate diagnosis and improve healthcare, with products aimed at hospitals, laboratories, and home testing.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Specialties

CEO

Brian J. Blaser

Employees

6,500

Headquarters

San Diego

Prihajajoči dogodki

04 NOV.

Earnings

Upcoming earnings report

43d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.